Jang Yang Chang

What is he best known for?

The fields of study he is best known for:

• Gene
• Cancer
• Enzyme

Jang Yang Chang mostly deals with Stereochemistry, Cancer research, Cancer, Cell culture and Biochemistry. His Stereochemistry study incorporates themes from IC50, In vitro, Chemical synthesis, Cytotoxicity and Combretastatin. His Cancer research research is multidisciplinary, incorporating elements of DNA damage, Carcinogenesis, Apoptosis, microRNA and Regulation of gene expression.

He is studying Cancer cell, which is a component of Cancer. His Cell culture research incorporates elements of Mitosis and Cell growth. The study of Biochemistry is intertwined with the study of Tubulin in a number of ways.

His most cited work include:

• BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo (174 citations)
• BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo (174 citations)
• Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents. (147 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Cancer research, Internal medicine, Cancer, Cancer cell and Stereochemistry. His studies in Cancer research integrate themes in fields like Cell growth, Carcinogenesis, Apoptosis, Downregulation and upregulation and microRNA. His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Chemotherapy.

Jang Yang Chang interconnects Cell and Cell biology in the investigation of issues within Cancer cell. His study in Stereochemistry is interdisciplinary in nature, drawing from both Cell culture, In vitro, Structure–activity relationship, Chemical synthesis and Combretastatin. His work carried out in the field of Cell culture brings together such families of science as Tubulin, Colchicine and Molecular biology.

He most often published in these fields:

• Cancer research (50.00%)
• Internal medicine (34.21%)
• Cancer (29.74%)

What were the highlights of his more recent work (between 2016-2021)?

• Cancer research (50.00%)
• Internal medicine (34.21%)
• Cancer (29.74%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, Internal medicine, Cancer, Head and neck cancer and Cancer cell. His Cancer research research includes themes of Epithelial–mesenchymal transition, Carcinogenesis, Head and neck squamous-cell carcinoma, Transforming growth factor and Western blot. His research on Internal medicine frequently connects to adjacent areas such as Oncology.

The Cancer study combines topics in areas such as DNA damage, Angiogenesis, Drug resistance and Germline. The study incorporates disciplines such as Odds ratio, Alcohol, Confidence interval and Risk factor in addition to Head and neck cancer. His study looks at the relationship between Cancer cell and fields such as Cell, as well as how they intersect with chemical problems.

Between 2016 and 2021, his most popular works were:

• New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. (57 citations)
• New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. (57 citations)
• Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells. (41 citations)

In his most recent research, the most cited papers focused on:

• Gene
• Cancer
• Enzyme

His primary areas of study are Cancer research, Carcinogenesis, Immunology, Cancer cell and microRNA. His Cancer research research integrates issues from Cancer, Colorectal cancer, Lymphangiogenesis, Signal transduction and Tube formation. His studies deal with areas such as DNA damage, Angiogenesis, Drug resistance and Cisplatin as well as Cancer.

His Immunology study integrates concerns from other disciplines, such as ALDH2, Oral Microbiome and Oral hygiene. His Cancer cell research includes elements of CDC42, Cell migration, A549 cell and Cell biology. His microRNA research is multidisciplinary, relying on both DNMT3B, Retinoic acid, ALDH1A2, Gene silencing and Epigenetics.